SA
GILD icon

Sanctuary Advisors’s Gilead Sciences GILD Stock Holding History

Sanctuary Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.7M Sell
203,044
-10,794
-5% -$1.42M 0.12% 180
2026
Q1 		$29.8M Sell
213,838
-7,673
-3% -$1.07M 0.16% 135
2025
Q4 		$27.2M Buy
221,511
+13,569
+7% +$1.65M 0.15% 138
2025
Q3 		$23.1M Sell
207,942
-3,984
-2% -$453K 0.13% 169
2025
Q2 		$23.5M Buy
211,926
+25,463
+14% +$2.71M 0.15% 150
2025
Q1 		$20.9M Buy
186,463
+14,456
+8% +$1.49M 0.15% 160
2024
Q4 		$16.7M Sell
172,007
-11,282
-6% -$1.02M 0.11% 205
2024
Q3 		$16.5M Buy
183,289
+40,951
+29% +$3.12M 0.1% 215
2024
Q2 		$9.31M Buy
+142,338
New +$9.5M 0.07% 302

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanctuary Advisors's GILD Position: Q2 2026 in Review

Sanctuary Advisors reduced its Gilead Sciences (GILD) stake by 5% in Q2 2026, selling an estimated $1.42M and leaving 203,044 shares worth $25.7M. The position accounts for 0.12% of the portfolio, ranked #180.

Sanctuary Advisors first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $29.8M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sanctuary Advisors held 203,044 shares of Gilead Sciences worth $25.7M as of Q2 2026.
  • Sanctuary Advisors sold 10,794 Gilead Sciences shares in Q2 2026, an estimated $1.42M.
  • Gilead Sciences made up 0.12% of Sanctuary Advisors's portfolio in Q2 2026, its #180 holding.
  • Sanctuary Advisors first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Gilead Sciences position peaked at $29.8M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.